The Hippo signaling pathway in stem cell biology and cancer

EMBO Reports

Volumn 15, Issue 6, 2014, Pages 642-656

  Mo, Jung Soon ^a   Park, Hyun Woo ^a   Guan, Kun Liang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cancer; Hippo pathway; regeneration; stem cell; YAP

Indexed keywords

CANCER STEM CELL; CELL DIFFERENTIATION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HIPPO PATHWAY; HUMAN; INTESTINE; LIVER CARCINOGENESIS; LIVER CELL; NEOPLASM; NERVOUS SYSTEM; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN; SKIN CELL; STEM CELL; BIOLOGICAL MODEL; HOMEOSTASIS; LIVER; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION;

G PROTEIN COUPLED RECEPTOR; HIPPO PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

EMBRYONIC DEVELOPMENT; HOMEOSTASIS; HUMANS; INTESTINES; LIVER; MODELS, BIOLOGICAL; NEOPLASMS; NERVOUS SYSTEM; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, G-PROTEIN-COUPLED; REGENERATION; SIGNAL TRANSDUCTION; SKIN; STEM CELLS;

EID: 84901774050     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.15252/embr.201438638     Document Type: Review

References (154)

1. Harvey KF, Pfleger CM, Hariharan IK, (2003) The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114: 457-467
2. Jia J, Zhang W, Wang B, Trinko R, Jiang J, (2003) The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev 17: 2514-2519
3. Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ, (1995) The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 9: 534-546
4. Pantalacci S, Tapon N, Leopold P, (2003) The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol 5: 921-927
5. Xu T, Wang W, Zhang S, Stewart RA, Yu W, (1995) Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 121: 1053-1063
6. Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G, (2003) Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol 5: 914-920
7. Wu S, Huang J, Dong J, Pan D, (2003) hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114: 445-456
8. Kango-Singh M, Nolo R, Tao C, Verstreken P, Hiesinger PR, Bellen HJ, Halder G, (2002) Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 129: 5719-5730
9. Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber D, Hariharan IK, (2002) salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110: 467-478
10. Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N, Ho LL, Li Y, (2005) Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120: 675-685
11. Huang J, Wu S, Barrera J, Matthews K, Pan D, (2005) The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122: 421-434
12. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D, (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133
13. Staley BK, Irvine KD, (2012) Hippo signaling in Drosophila: recent advances and insights. Dev Dyn 241: 3-15
14. Oh H, Irvine KD, (2008) In vivo regulation of Yorkie phosphorylation and localization. Development 135: 1081-1088
15. Ren F, Zhang L, Jiang J, (2010) Hippo signaling regulates Yorkie nuclear localization and activity through 14-3-3 dependent and independent mechanisms. Dev Biol 337: 303-312
16. Mahoney WM Jr, Hong JH, Yaffe MB, Farrance IK, (2005) The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J 388: 217-225
17. Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML, (2001) TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev 15: 1229-1241
18. Peng HW, Slattery M, Mann RS, (2009) Transcription factor choice in the Hippo signaling pathway: homothorax and yorkie regulation of the microRNA bantam in the progenitor domain of the Drosophila eye imaginal disc. Genes Dev 23: 2307-2319
19. Oh H, Irvine KD, (2011) Cooperative regulation of growth by Yorkie and Mad through bantam. Dev Cell 20: 109-122
20. Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA, Sillje HH, (2005) The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24: 2076-2086
21. Praskova M, Xia F, Avruch J, (2008) MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol 18: 311-321
22. Callus BA, Verhagen AM, Vaux DL, (2006) Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J 273: 4264-4276
23. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL, (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24: 72-85
24. Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, et al, (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971
25. Wang K, Degerny C, Xu M, Yang XJ, (2009) YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem Cell Biol 87: 77-91
26. McCartney BM, Kulikauskas RM, LaJeunesse DR, Fehon RG, (2000) The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiation. Development 127: 1315-1324
27. Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, Tao C, Jafar-Nejad H, Halder G, (2006) The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol 8: 27-36
28. Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H, (2010) The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell 18: 309-316
29. Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N, (2010) Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 18: 300-308
30. Yu J, Zheng Y, Dong J, Klusza S, Deng WM, Pan D, (2010) Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell 18: 288-299
31. Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, Larsen BG, Rossant J, Wrana JL, (2010) The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev Cell 19: 831-844
32. Chen CL, Gajewski KM, Hamaratoglu F, Bossuyt W, Sansores-Garcia L, Tao C, Halder G, (2010) The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila. Proc Natl Acad Sci U S A 107: 15810-15815
33. Robinson BS, Huang J, Hong Y, Moberg KH, (2010) Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein Expanded. Curr Biol 20: 582-590
34. Grzeschik NA, Parsons LM, Allott ML, Harvey KF, Richardson HE, (2010) Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr Biol 20: 573-581
35. Ling C, Zheng Y, Yin F, Yu J, Huang J, Hong Y, Wu S, Pan D, (2010) The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded. Proc Natl Acad Sci U S A 107: 10532-10537
36. Martin-Belmonte F, Perez-Moreno M, (2012) Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 12: 23-38
37. Menendez J, Perez-Garijo A, Calleja M, Morata G, (2010) A tumor-suppressing mechanism in Drosophila involving cell competition and the Hippo pathway. Proc Natl Acad Sci U S A 107: 14651-14656
38. Remue E, Meerschaert K, Oka T, Boucherie C, Vandekerckhove J, Sudol M, Gettemans J, (2010) TAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent manner. FEBS Lett 584: 4175-4180
39. Oka T, Remue E, Meerschaert K, Vanloo B, Boucherie C, Gfeller D, Bader GD, Sidhu SS, Vandekerckhove J, Gettemans J, et al, (2010) Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling. Biochem J 432: 461-472
40. Kim NG, Koh E, Chen X, Gumbiner BM, (2011) E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci U S A 108: 11930-11935
41. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp TR, et al, (2011) Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144: 782-795
42. Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD, Lantz DM, Seykora JT, Vasioukhin V, (2011) alpha-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci Signal 4: ra33
43. Liu X, Yang N, Figel SA, Wilson KE, Morrison CD, Gelman IH, Zhang J, (2013) PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene 32: 1266-1273
44. Wang W, Huang J, Wang X, Yuan J, Li X, Feng L, Park JI, Chen J, (2012) PTPN14 is required for the density-dependent control of YAP1. Genes Dev 26: 1959-1971
45. Huang JM, Nagatomo I, Suzuki E, Mizuno T, Kumagai T, Berezov A, Zhang H, Karlan B, Greene MI, Wang Q, (2013) YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene 32: 2220-2229
46. Das Thakur M, Feng Y, Jagannathan R, Seppa MJ, Skeath JB, Longmore GD, (2010) Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr Biol 20: 657-662
47. Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD, (2011) Zyxin links fat signaling to the hippo pathway. PLoS Biol 9: e1000624
48. Mao Y, Mulvaney J, Zakaria S, Yu T, Morgan KM, Allen S, Basson MA, Francis-West P, Irvine KD, (2011) Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development. Development 138: 947-957
49. Bossuyt W, Chen CL, Chen Q, Sudol M, McNeill H, Pan D, Kopp A, Halder G, (2014) An evolutionary shift in the regulation of the Hippo pathway between mice and flies. Oncogene 33: 1218-1228
50. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, et al, (2011) Role of YAP/TAZ in mechanotransduction. Nature 474: 179-183
51. Wada K, Itoga K, Okano T, Yonemura S, Sasaki H, (2011) Hippo pathway regulation by cell morphology and stress fibers. Development 138: 3907-3914
52. Zhao B, Li L, Wang L, Wang CY, Yu J, Guan KL, (2012) Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev 26: 54-68
53. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, et al, (2012) Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150: 780-791
54. Mo JS, Yu FX, Gong R, Brown JH, Guan KL, (2012) Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev 26: 2138-2143
55. Miller E, Yang J, DeRan M, Wu C, Su AI, Bonamy GM, Liu J, Peters EC, Wu X, (2012) Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Chem Biol 19: 955-962
56. Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, Dupont S, Piccolo S, (2013) A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154: 1047-1059
57. Boggiano JC, Vanderzalm PJ, Fehon RG, (2011) Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway. Dev Cell 21: 888-895
58. Poon CL, Lin JI, Zhang X, Harvey KF, (2011) The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway. Dev Cell 21: 896-906
59. Huang HL, Wang S, Yin MX, Dong L, Wang C, Wu W, Lu Y, Feng M, Dai C, Guo X, et al, (2013) Par-1 regulates tissue growth by influencing hippo phosphorylation status and hippo-salvador association. PLoS Biol 11: e1001620
60. Mohseni M, Sun J, Lau A, Curtis S, Goldsmith J, Fox VL, Wei C, Frazier M, Samson O, Wong KK, et al, (2014) A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway. Nat Cell Biol 16: 108-117
61. Wehr MC, Holder MV, Gailite I, Saunders RE, Maile TM, Ciirdaeva E, Instrell R, Jiang M, Howell M, Rossner MJ, et al, (2013) Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila. Nat Cell Biol 15: 61-71
62. Praskova M, Khoklatchev A, Ortiz-Vega S, Avruch J, (2004) Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem J 381: 453-462
63. Ikeda M, Kawata A, Nishikawa M, Tateishi Y, Yamaguchi M, Nakagawa K, Hirabayashi S, Bao Y, Hidaka S, Hirata Y, et al, (2009) Hippo pathway-dependent and -independent roles of RASSF6. Sci Signal 2: ra59
64. Sidor CM, Brain R, Thompson BJ, (2013) Mask proteins are cofactors of Yorkie/YAP in the Hippo pathway. Curr Biol 23: 223-228
65. Sansores-Garcia L, Atkins M, Moya IM, Shahmoradgoli M, Tao C, Mills GB, Halder G, (2013) Mask is required for the activity of the Hippo pathway effector Yki/YAP. Curr Biol 23: 229-235
66. Poon CL, Zhang X, Lin JI, Manning SA, Harvey KF, (2012) Homeodomain-interacting protein kinase regulates Hippo pathway-dependent tissue growth. Curr Biol 22: 1587-1594
67. Chen J, Verheyen EM, (2012) Homeodomain-interacting protein kinase regulates Yorkie activity to promote tissue growth. Curr Biol 22: 1582-1586
68. Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D, Li T, Chan SW, Lim CJ, Hong W, et al, (2010) The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. J Biol Chem 285: 37159-37169
69. Cockburn K, Rossant J, (2010) Making the blastocyst: lessons from the mouse. J Clin Invest 120: 995-1003
70. Morin-Kensicki EM, Boone BN, Howell M, Stonebraker JR, Teed J, Alb JG, Magnuson TR, O'Neal W, Milgram SL, (2006) Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol Cell Biol 26: 77-87
71. Yagi R, Kohn MJ, Karavanova I, Kaneko KJ, Vullhorst D, DePamphilis ML, Buonanno A, (2007) Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development. Development 134: 3827-3836
72. Chen Z, Friedrich GA, Soriano P, (1994) Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev 8: 2293-2301
73. Sawada A, Kiyonari H, Ukita K, Nishioka N, Imuta Y, Sasaki H, (2008) Redundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survival. Mol Cell Biol 28: 3177-3189
74. Nishioka N, Yamamoto S, Kiyonari H, Sato H, Sawada A, Ota M, Nakao K, Sasaki H, (2008) Tead4 is required for specification of trophectoderm in pre-implantation mouse embryos. Mech Dev 125: 270-283
75. Ralston A, Cox BJ, Nishioka N, Sasaki H, Chea E, Rugg-Gunn P, Guo G, Robson P, Draper JS, Rossant J, (2010) Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2. Development 137: 395-403
76. Nishioka N, Inoue K, Adachi K, Kiyonari H, Ota M, Ralston A, Yabuta N, Hirahara S, Stephenson RO, Ogonuki N, et al, (2009) The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell 16: 398-410
77. Cockburn K, Biechele S, Garner J, Rossant J, (2013) The Hippo pathway member Nf2 is required for inner cell mass specification. Curr Biol 23: 1195-1201
78. Hirate Y, Hirahara S, Inoue K, Suzuki A, Alarcon VB, Akimoto K, Hirai T, Hara T, Adachi M, Chida K, et al, (2013) Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos. Curr Biol 23: 1181-1194
79. Hossain Z, Ali SM, Ko HL, Xu J, Ng CP, Guo K, Qi Z, Ponniah S, Hong W, Hunziker W, (2007) Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc Natl Acad Sci U S A 104: 1631-1636
80. Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW, Wrana JL, (2008) TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 10: 837-848
81. Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, et al, (2009) Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139: 757-769
82. Biswas A, Hutchins R, (2007) Embryonic stem cells. Stem Cells Dev 16: 213-222
83. Darr H, Benvenisty N, (2006) Human embryonic stem cells: the battle between self-renewal and differentiation. Regen Med 1: 317-325
84. Xiao L, Yuan X, Sharkis SJ, (2006) Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24: 1476-1486
85. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA, (2002) "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298: 597-600
86. Tamm C, Bower N, Anneren C, (2011) Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF. J Cell Sci 124: 1136-1144
87. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, Israel MA, Goldstein LS, Abujarour R, et al, (2010) The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 24: 1106-1118
88. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676
89. Murakami M, Tominaga J, Makita R, Uchijima Y, Kurihara Y, Nakagawa O, Asano T, Kurihara H, (2006) Transcriptional activity of Pax3 is co-activated by TAZ. Biochem Biophys Res Commun 339: 533-539
90. Michalopoulos GK, (2007) Liver regeneration. J Cell Physiol 213: 286-300
91. Halder G, Johnson RL, (2011) Hippo signaling: growth control and beyond. Development 138: 9-22
92. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, Brummelkamp TR, (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17: 2054-2060
93. Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, Liu JO, Pan D, (2012) Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 26: 1300-1305
94. Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, Chen Y, Park O, Chang J, Simpson RM, et al, (2010) Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci U S A 107: 1431-1436
95. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, Lauwers GY, Thasler W, Lee JT, Avruch J, et al, (2009) Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16: 425-438
96. Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, Wang Y, Halder G, Finegold MJ, Lee JS, et al, (2010) Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A 107: 1437-1442
97. Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS, Kim MC, Jeong WI, Calvisi DF, Kim JM, et al, (2010) The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci U S A 107: 8248-8253
98. Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J, Giovannini M, Liu P, Anders RA, Pan D, (2010) The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell 19: 27-38
99. Benhamouche S, Curto M, Saotome I, Gladden AB, Liu CH, Giovannini M, McClatchey AI, (2010) Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev 24: 1718-1730
100. Fuchs E, Chen T, (2013) A matter of life and death: self-renewal in stem cells. EMBO Rep 14: 39-48
101. Lee JH, Kim TS, Yang TH, Koo BK, Oh SP, Lee KP, Oh HJ, Lee SH, Kong YY, Kim JM, et al, (2008) A crucial role of WW45 in developing epithelial tissues in the mouse. EMBO J 27: 1231-1242
102. Zhang H, Pasolli HA, Fuchs E, (2011) Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc Natl Acad Sci U S A 108: 2270-2275
103. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, et al, (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761
104. Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, Guan KL, (2011) Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25: 51-63
105. Ma DK, Bonaguidi MA, Ming GL, Song H, (2009) Adult neural stem cells in the mammalian central nervous system. Cell Res 19: 672-682
106. Cao X, Pfaff SL, Gage FH, (2008) YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev 22: 3320-3334
107. Gee ST, Milgram SL, Kramer KL, Conlon FL, Moody SA, (2011) Yes-associated protein 65 (YAP) expands neural progenitors and regulates Pax3 expression in the neural plate border zone. PLoS ONE 6: e20309
108. Milewski RC, Chi NC, Li J, Brown C, Lu MM, Epstein JA, (2004) Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3. Development 131: 829-837
109. Fernandez LA, Northcott PA, Dalton J, Fraga C, Ellison D, Angers S, Taylor MD, Kenney AM, (2009) YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev 23: 2729-2741
110. Kagey JD, Brown JA, Moberg KH, (2012) Regulation of Yorkie activity in Drosophila imaginal discs by the Hedgehog receptor gene patched. Mech Dev 129: 339-349
111. Van Hateren NJ, Das RM, Hautbergue GM, Borycki AG, Placzek M, Wilson SA, (2011) FatJ acts via the Hippo mediator Yap1 to restrict the size of neural progenitor cell pools. Development 138: 1893-1902
112. Lavado A, He Y, Pare J, Neale G, Olson EN, Giovannini M, Cao X, (2013) Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators. Development 140: 3323-3334
113. Cho E, Feng Y, Rauskolb C, Maitra S, Fehon R, Irvine KD, (2006) Delineation of a Fat tumor suppressor pathway. Nat Genet 38: 1142-1150
114. Cappello S, Gray MJ, Badouel C, Lange S, Einsiedler M, Srour M, Chitayat D, Hamdan FF, Jenkins ZA, Morgan T, et al, (2013) Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development. Nat Genet 45: 1300-1308
115. Nadal-Ginard B, Kajstura J, Leri A, Anversa P, (2003) Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92: 139-150
116. Yamamoto S, Yang G, Zablocki D, Liu J, Hong C, Kim SJ, Soler S, Odashima M, Thaisz J, Yehia G, et al, (2003) Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J Clin Invest 111: 1463-1474
117. Matsui Y, Nakano N, Shao D, Gao S, Luo W, Hong C, Zhai P, Holle E, Yu X, Yabuta N, et al, (2008) Lats2 is a negative regulator of myocyte size in the heart. Circ Res 103: 1309-1318
118. Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, Martin JF, (2011) Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332: 458-461
119. Xin M, Kim Y, Sutherland LB, Qi X, McAnally J, Schwartz RJ, Richardson JA, Bassel-Duby R, Olson EN, (2011) Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci Signal 4: ra70
120. Xin M, Kim Y, Sutherland LB, Murakami M, Qi X, McAnally J, Porrello ER, Mahmoud AI, Tan W, Shelton JM, et al, (2013) Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci U S A 110: 13839-13844
121. von Gise A, Lin Z, Schlegelmilch K, Honor LB, Pan GM, Buck JN, Ma Q, Ishiwata T, Zhou B, Camargo FD, et al, (2012) YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci U S A 109: 2394-2399
122. Judson RN, Tremblay AM, Knopp P, White RB, Urcia R, De Bari C, Zammit PS, Camargo FD, Wackerhage H, (2012) The Hippo pathway member Yap plays a key role in influencing fate decisions in muscle satellite cells. J Cell Sci 125: 6009-6019
123. Watt KI, Judson R, Medlow P, Reid K, Kurth TB, Burniston JG, Ratkevicius A, De Bari C, Wackerhage H, (2010) Yap is a novel regulator of C2C12 myogenesis. Biochem Biophys Res Commun 393: 619-624
124. Jeong H, Bae S, An SY, Byun MR, Hwang JH, Yaffe MB, Hong JH, Hwang ES, (2010) TAZ as a novel enhancer of MyoD-mediated myogenic differentiation. FASEB J 24: 3310-3320
125. Barry ER, Camargo FD, (2013) The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development. Curr Opin Cell Biol 25: 247-253
126. Barker N, (2014) Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol 15: 19-33
127. Johnson R, Halder G, (2014) The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov 13: 63-79
128. Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, Pan D, (2010) The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 24: 2383-2388
129. Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E, Dawson D, Willis JE, Markowitz SD, Camargo FD, et al, (2011) Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U S A 108: E1312-E1320
130. Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S, et al, (2013) Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493: 106-110
131. Karpowicz P, Perez J, Perrimon N, (2010) The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development 137: 4135-4145
132. Staley BK, Irvine KD, (2010) Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Curr Biol 20: 1580-1587
133. Ren F, Wang B, Yue T, Yun EY, Ip YT, Jiang J, (2010) Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc Natl Acad Sci U S A 107: 21064-21069
134. Pan D, (2010) The hippo signaling pathway in development and cancer. Dev Cell 19: 491-505
135. Zhao B, Lei QY, Guan KL, (2008) The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 20: 638-646
136. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, et al, (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125: 1253-1267
137. Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D, Montgomery EA, Anders RA, (2008) Expression of Yes-associated protein in common solid tumors. Hum Pathol 39: 1582-1589
138. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W, Zeng Q, Hong W, (2008) A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 68: 2592-2598
139. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, et al, (2011) The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147: 759-772
140. Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL, Kim SH, et al, (2011) The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev 25: 2594-2609
141. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, Deng CX, Brugge JS, Haber DA, (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A 103: 12405-12410
142. Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, Akatsuka S, Horio Y, Hida T, Kondo Y, et al, (2011) LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res 71: 873-883
143. St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, Brownstein DG, Parlow AF, McGrath J, Xu T, (1999) Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet 21: 182-186
144. Takahashi Y, Miyoshi Y, Takahata C, Irahara N, Taguchi T, Tamaki Y, Noguchi S, (2005) Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin Cancer Res 11: 1380-1385
145. Jiang Z, Li X, Hu J, Zhou W, Jiang Y, Li G, Lu D, (2006) Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. Neurosci Res 56: 450-458
146. Seidel C, Schagdarsurengin U, Blumke K, Wurl P, Pfeifer GP, Hauptmann S, Taubert H, Dammann R, (2007) Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma. Mol Carcinog 46: 865-871
147. Evans DG, (2009) Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]. Genet Med 11: 599-610
148. Thurneysen C, Opitz I, Kurtz S, Weder W, Stahel RA, Felley-Bosco E, (2009) Functional inactivation of NF2/merlin in human mesothelioma. Lung Cancer 64: 140-147
149. Bianchi AB, Mitsunaga SI, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJ, Testa JR, (1995) High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci U S A 92: 10854-10858
150. Tanas MR, Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ, Flanagan J, Luo Y, Fenwick K, Natrajan R, et al, (2011) Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med 3: 98ra82
151. Errani C, Zhang L, Sung YS, Hajdu M, Singer S, Maki RG, Healey JH, Antonescu CR, (2011) A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosom Cancer 50: 644-653
152. Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM, Harbour JW, (2008) Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 49: 5230-5234
153. Prickett TD, Wei X, Cardenas-Navia I, Teer JK, Lin JC, Walia V, Gartner J, Jiang J, Cherukuri PF, Molinolo A, et al, (2011) Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. Nat Genet 43: 1119-1126
154. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J, et al, (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869-873